FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...

The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets.

There are problems with generative AI, and there need to be guardrails and there needs to be human oversight," said Jason ...

The U.S. Food and Drug Administration (“FDA”) has fast-tracked the rollout of its AI tool, Elsa, originally planned for June 30, with Commissioner Dr ...

Writing for SBM these days is a bit like being in one of those cash grab machines, though instead of money flying over the place, it’s bees and wasps. Every week brings a fresh round of horrors that ...

From STAT’s Adam Feuerstein: Another example of why biotech is a tough business.

To prepare you for this weekend's Davis vs. De Los Santos boxing card, we look at when the main card fighters are expected to ...